Showing results (3151-3160 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|November 2, 2023
The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinomaLiqiu Kou, Xiaolu Xie, Xiu Chen, et al.Cancer Immunology, Immunotherapy : CII|October 17, 2023
Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustionKumaravel Mohankumar, Gus Wright, Subhashree Kumaravel, et al.Cancer Immunology, Immunotherapy : CII|October 10, 2023
The influence of plasma sPD-L1 concentration on the effectiveness of immunotherapy in advanced NSCLC patientsIzabela Chmielewska, Anna Grenda, Paweł Krawczyk, et al.Cancer Immunology, Immunotherapy : CII|October 5, 2023
An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1Haibin Deng, Huixiang Ge, Christelle Dubey, et al.Cancer Immunology, Immunotherapy : CII|October 13, 2023
A novel CD47-blocking peptide fused to pro-apoptotic KLA repeat inhibits lung cancer growth in miceLinyue Pan, Lu Hu, Mengjie Chen, et al.Cancer Immunology, Immunotherapy : CII|July 21, 2023
Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemiaP K J D de Jonge, P M M van Hauten, L D Janssen, et al.Cancer Immunology, Immunotherapy : CII|July 10, 2023
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitorsFabrizio Nelli, Diana Giannarelli, Agnese Fabbri, et al.Cancer Immunology, Immunotherapy : CII|July 18, 2023
Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapySiqi Xiong, Wenqiang Zhu, Liqing Wu, et al.Cancer Immunology, Immunotherapy : CII|July 27, 2023
Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1Wenjie Li, Wei WangCancer Immunology, Immunotherapy : CII|July 7, 2023
CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancerPeiwei Yang, Fan Yu, Zheng Yao, et al.Pageof 652